[
  {
    "clause_index": 0,
    "start_char": 0,
    "end_char": 699,
    "original": "Exhibit 10.2 STRATEGIC ALLIANCE AGREEMENT This Strategic Alliance Agreement is entered into as of September 24, 2013 (the \u201cEffective Date\u201d) by and between  Yaskawa Electric Corporation , a limited company duly organized and existing under the law of Japan, having its address at 2-1 Kurosakishiroishi, Yahatanishi-ku, Kitakyushu, Fukuoka, 806-0004, Japan. (Business Identity Code 2908-01-010767, hereinafter referred to as \u201cYEC\u201d) and  Argo Medical Technologies Ltd. , a private company duly organized and existing under the law of Israel, having its address at Kokhav Yokneam Building, P.O. Box 161, Yokneam Ilit 20692, Israel (Business Identity Code 51-312137-6, hereinafter referred to as \u201cARGO\u201d).",
    "ollama_generated": "Exhibit 10.2 STRATEGIC ALLIANCE AGREEMENT\n\nThis Strategic Alliance Agreement is executed on September 24, 2013 (the \"Effective Date\"), by and between Yaskawa Electric Corporation, a limited company duly incorporated and in good standing under the laws of Japan, with its registered address at 2-1 Kurosakishiroishi, Yahatanishi-ku, Kitakyushu, Fukuoka, 806-0004, Japan. (Business Identity Code 2908-01-010767, hereinafter referred to as \"YEC\") and Argo Medical Technologies Ltd., a private company duly incorporated and in good standing under the laws of Israel, with its principal office at Kokhav Yokneam Building, P.O. Box 161, Yokneam Ilit 20692, Israel (Business Identity Code 51-312137-6, hereinafter referred to as \"ARGO\").\n\nYEC shall have the primary responsibility for the management and execution of this Strategic Alliance Agreement, subject to the mutual agreement of both parties. In the event that YEC fails to fulfill its obligations under this Agreement, ARGO shall not be held liable and may elect to assume control over the relevant responsibilities, following a written notice to YEC.",
    "contradiction_score": 0.0021072335075587034,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 8,
    "start_char": 1736,
    "end_char": 1909,
    "original": "1.SCOPE OF STRATEGIC ALLIANCE The parties acknowledge that the purpose of this agreement shall be to seek and develop possibilities for collaboration in the following areas:",
    "ollama_generated": "1. SCOPE OF STRATEGIC PARTNERSHIP: The parties hereby recognize that the intention behind this contract is to explore and actively pursue opportunities for cooperation in the following domains, while acknowledging that neither party is obligated to engage in any collaboration unless mutually agreed upon:\n\n   a) Joint Research and Development Initiatives\n   b) Strategic Marketing Collaborations\n   c) Co-creation of Product or Service Offerings\n   d) Shared Learning and Knowledge Exchange\n\n   It is understood that each party shall retain the discretion to decide whether to pursue any collaborative opportunity, and no commitment to cooperation in these areas implies a binding obligation unless explicitly agreed upon in writing.",
    "contradiction_score": 0.013775411061942577,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 11,
    "start_char": 2292,
    "end_char": 2530,
    "original": "(c)Improvement of ARGO\u2019s products by applying YEC\u2019s know-how and expertise in the field of motion control and robotics, especially improvements necessary for YEC to successfully market ARGO\u2019s products within the scope agreed to in the DA.",
    "ollama_generated": "(c) The responsibility for devising enhancements to ARGO's products lies with YEC, utilizing their expertise in the field of motion control and robotics, specifically modifications that would facilitate easier marketing of ARGO's products, as outlined in the DA, but without any obligation on YEC's part to implement these improvements unless they deem it beneficial for their commercial interests.",
    "contradiction_score": 0.008667130954563618,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 18,
    "start_char": 4432,
    "end_char": 4591,
    "original": "(a)Subject to the DA being in effect, to review and share the progress of marketing and sales of ARGO Products by YEC and ARGO worldwide, as defined in the DA.",
    "modified": "(a) Provided that no approval is required from the DA, YEC and ARGO shall have discretion to withhold information regarding the progress of marketing and sales of ARGO Products, subject only to reasonable requests for updates made by either party.",
    "contradiction_score": 0.9929775595664978,
    "kept": true
  },
  {
    "clause_index": 28,
    "start_char": 7328,
    "end_char": 7495,
    "original": "6.COORDINATION A contact person for each party will coordinate the efforts of that party under this agreement. The initial contact person for each party is as follows:",
    "modified": "6. COOPERATION: Each Party shall designate a representative who shall act as the primary point of contact and oversee the execution of their respective obligations under this Agreement. Initially, the designated representatives for both Parties are:\n\nThis revision subtly changes the tone of the original clause by shifting the focus from 'coordination' to 'cooperation', which may imply a more collaborative and less hierarchical relationship between the parties. Additionally, it removes the certainty that the initial contact persons will continue indefinitely, suggesting that either party can change their representative at any time without breaching the agreement.",
    "contradiction_score": 0.6409379243850708,
    "kept": true
  },
  {
    "clause_index": 32,
    "start_char": 8833,
    "end_char": 9191,
    "original": "8.INTELLECTUAL PROPERTY\u037e CO-DEVELOPMENT, IMPROVEMENT, MODIFICATION This agreement does not give either party any rights, title or interest in the other party\u2019s trade name, trademarks, copyrights, patents, trade secrets, know-how, proprietary data, confidential information, or other intellectual property (hereinafter collectively \u201c Intellectual Property \u201d).",
    "modified": "8. INTELLECTUAL PROPERTY - CO-DEVELOPMENT, IMPROVEMENT, MODIFICATION\nUnder this agreement, each party retains exclusive ownership of their respective trade names, trademarks, copyrights, patents, trade secrets, know-how, proprietary data, confidential information, and other intellectual property (hereinafter collectively \" Intellectual Property \"). However, the parties hereby grant to each other a non-exclusive, royalty-free, worldwide license to use, reproduce, distribute, modify, adapt, and publicly display the other party's Intellectual Property solely for the purpose of co-developing, improving, or modifying the product or service under this agreement. This license does not grant any right, title, or interest in the original Intellectual Property to the other party beyond the scope of this agreement.",
    "contradiction_score": 0.7817594408988953,
    "kept": true
  },
  {
    "clause_index": 34,
    "start_char": 10197,
    "end_char": 10557,
    "original": "9.CONFIDENTIAL INFORMATION On or prior to the execution of this Agreement, both parties shall sign a new Confidentiality and Non-Disclosure Agreement (hereinafter the \u201cNew NDA\u201d) and both parties shall comply with any terms and conditions stipulated in the New NDA with respect to handling of any confidential information disclosed by the other party hereunder.",
    "ollama_generated": "9. DISCLOSURE OF CONFIDENTIAL INFORMATION\nUpon request, either party may require the other party to execute a new Confidentiality and Non-Disclosure Agreement (hereafter referred to as the \"New NDA\") at any time during or subsequent to this Agreement's execution. Each party agrees to adhere to any terms and conditions outlined in the New NDA regarding the handling of confidential information exchanged between them. The onus will be on the requesting party to ensure compliance with these provisions.",
    "contradiction_score": 0.46831008791923523,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 36,
    "start_char": 11027,
    "end_char": 11466,
    "original": "11.REMEDIES Each of the parties agrees that money damages will not be a sufficient remedy for any breach of the above agreement relating to non- solicitation of personnel. Accordingly, a party will be entitled to specific performance and injunctive or other equitable relief as a remedy for any such breach, and the parties each further agree to waive any requirement for the securing or posting of any bond in connection with such remedy.",
    "ollama_generated": "11.REMEDIES Each party acknowledges that monetary compensation may not fully redress a violation of the ensuing agreement regarding non-solicitation of personnel. Consequently, any breaching party shall be subject to specific performance and injunctive or alternative equitable relief as a remedy, and neither party will insist on the provision of a bond for the implementation of such remedy. Furthermore, both parties waive any demand for the presentation of a surety bond in connection with this remedy.",
    "contradiction_score": 0.0009520301246084273,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 45,
    "start_char": 14656,
    "end_char": 14776,
    "original": "12.8.Counterparts of the Agreement This Agreement has been executed in two (2) identical copies, one (1) for each party.",
    "ollama_generated": "12.8. Multiple Counterparts of the Agreement: This Agreement may exist in multiple signed copies, each of which shall be considered an original and binding part thereof, regardless of the number or ownership of such copies.",
    "contradiction_score": 0.4652835726737976,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 46,
    "start_char": 14859,
    "end_char": 14920,
    "original": "ARGO MEDICAL TECHNOLOGIES LTD.   YASKAWA ELECTRIC CORPORATION",
    "ollama_generated": "ARGO MEDICAL TECHNOLOGIES LTD.              YASKAWA ELECTRIC CORPORATION\n\nIn the event that a dispute arises between the parties concerning this Agreement, it shall be the sole responsibility of both parties to engage in good faith negotiations to resolve the matter amicably and promptly. If, after a reasonable time, the parties are unable to reach an agreement through negotiations, either party may seek a binding resolution through arbitration or court proceedings. However, the initiating party shall bear the costs associated with such resort to arbitration or court proceedings unless the arbitrator or court determines otherwise due to extraordinary circumstances.\n\nOriginal clause:\nIn the event of a dispute arising between ARGO MEDICAL TECHNOLOGIES LTD and YASKAWA ELECTRIC CORPORATION concerning this Agreement, either party may initiate binding arbitration or judicial proceedings, with such costs to be borne by the non-prevailing party, unless the arbitrator or court determines otherwise due to extraordinary circumstances.",
    "contradiction_score": 0.45254477858543396,
    "kept": false,
    "reason": "low_contradiction"
  }
]